Vaxcyte Ownership | Who Owns Vaxcyte?

Overview ForecastFinancials Chart Transcripts

Vaxcyte Ownership Summary

Vaxcyte is owned by 20.82% institutional investors, 0.66% insiders, and 78.52% retail investors. Fmr is the largest institutional shareholder, holding 10.58% of PCVX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.04% of its assets in Vaxcyte shares.

PCVX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Vaxcyte	20.82%	0.66%	78.52%
Sector	Healthcare Stocks	279.18%	10.62%	-189.80%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	13.09M	10.58%	$1.07B
Vanguard group	11.96M	9.67%	$979.18M
Ra capital management	12.19M	8.98%	$460.26M
Blackrock funding, inc. /de	11.11M	8.98%	$909.14M
Janus henderson group	10.58M	8.55%	$865.61M
Blackrock	9.94M	8.48%	$750.56M
Capital research global investors	6.21M	5.02%	$508.39M
Wellington management group llp	4.44M	3.59%	$363.79M
Price t rowe associates inc /md/	3.97M	3.21%	$324.74M
State street	3.37M	2.87%	$254.25M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Pivotal bioventure partners investment advisor	710.73K	21.72%	$26.84M
Kynam capital management, lp	3.20M	10.15%	$120.83M
Ra capital management	12.19M	7.69%	$460.26M
Saturn v capital management	204.28K	6.55%	$16.72M
Commodore capital lp	1.65M	4.59%	$62.30M
Ghost tree capital	150.00K	3.55%	$11.33M
Paradigm biocapital advisors lp	1.70M	2.93%	$64.06M
Novo	915.00K	2.63%	$34.55M
Great point partners	115.52K	2.31%	$4.36M
Eversept partners, lp	557.07K	2.14%	$21.03M

Top Buyers

Holder	Shares	% Assets	Change
Ra capital management	12.19M	7.69%	3.50M
Goldman sachs group	3.13M	0.04%	2.18M
Capital research global investors	6.21M	0.10%	1.31M
Norges bank	1.10M	0.01%	1.10M
Kynam capital management, lp	3.20M	10.15%	863.20K

Top Sellers

Holder	Shares	% Assets	Change
Fmr	13.09M	0.06%	-2.71M
Darwin global management	-	-	-2.20M
T. rowe price investment management	2.86M	0.14%	-1.19M
Perceptive advisors	706.57K	0.94%	-1.01M
Fred alger management	523.01K	0.20%	-720.71K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	1.10M	0.01%	1.10M	$90.07M
Deep track capital, lp	750.00K	0.92%	750.00K	$28.32M
Lazard asset management	486.76K	0.06%	486.76K	$39.85M
Twinbeech capital lp	279.94K	0.39%	279.94K	$22.92M
Raymond james financial	264.70K	0.01%	264.70K	$21.67M

Sold Out

Holder	Change
Dinuzzo private wealth	-1.00
Jfs wealth advisors	-1.00
Global financial private client	-1.00
Mai capital management	-2.00
Capital performance advisors llp	-3.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	35	-89.64%	28,246,930	-79.94%	20	0.16%	20	-90.10%	6	-93.02%
Dec 31, 2024	130	-62.54%	38,665,990	-71.44%	31	0.26%	83	-61.03%	32	-63.64%
Sep 30, 2024	344	25.09%	135,391,305	10.49%	109	1.00%	210	32.08%	88	18.92%
Jun 30, 2024	275	5.36%	122,540,457	3.83%	104	0.94%	159	7.43%	74	-6.33%
Mar 31, 2024	261	14.47%	118,023,704	14.54%	105	0.94%	148	18.40%	79	16.18%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	3.92M	3.04%	41.57K
Vanguard Health Care Inv	3.87M	3.00%	1.32M
Vanguard US Total Market Shares ETF	3.67M	2.85%	587.74K
iShares Russell 2000 ETF	3.18M	2.46%	1.56K
Vanguard Small Cap Index	3.07M	2.38%	17.44K
Janus Henderson Forty S	2.16M	1.67%	174.00K
Janus Concentrated Growth CF	2.16M	1.67%	633.38K
American Funds SMALLCAP World A	2.15M	1.67%	-230.42K
American Funds Growth Fund of Amer A	1.91M	1.48%	-3.19K
Capital Group Growth Fnd of Amer Comp	1.91M	1.48%	-3.19K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 05, 2025	Eydelman Mikhail	SVP, GEN COUNSEL & CORP SEC	Sell	$8.11K
Mar 05, 2025	Eydelman Mikhail	SVP, GEN COUNSEL & CORP SEC	Sell	$184.49K
Mar 05, 2025	Eydelman Mikhail	SVP, GEN COUNSEL & CORP SEC	Sell	$161.11K
Mar 03, 2025	Wassil Jim	CHIEF OPERATING OFFICER	Sell	$153.95K
Mar 03, 2025	Wassil Jim	CHIEF OPERATING OFFICER	Sell	$432.21K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	32
2024 Q4	-	68
2024 Q3	-	54
2024 Q2	-	46

PCVX Ownership FAQ

Who Owns Vaxcyte?

Vaxcyte shareholders are primarily institutional investors at 20.82%, followed by 0.66% insiders and 78.52% retail investors. The average institutional ownership in Vaxcyte's industry, Biotech Stocks , is 63.96%, which Vaxcyte falls below.

Who owns the most shares of Vaxcyte?

Vaxcyte’s largest shareholders are Fmr (13.09M shares, 10.58%), Vanguard group (11.96M shares, 9.67%), and Ra capital management (12.19M shares, 8.98%). Together, they hold 29.24% of Vaxcyte’s total shares outstanding.

Does Blackrock own Vaxcyte?

Yes, BlackRock owns 8.48% of Vaxcyte, totaling 9.94M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 750.56M$. In the last quarter, BlackRock increased its holdings by 426.84K shares, a 4.49% change.

Who is Vaxcyte’s biggest shareholder by percentage of total assets invested?

Pivotal bioventure partners investment advisor is Vaxcyte’s biggest shareholder by percentage of total assets invested, with 21.72% of its assets in 710.73K Vaxcyte shares, valued at 26.84M$.

Who is the top mutual fund holder of Vaxcyte shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Vaxcyte shares, with 3.04% of its total shares outstanding invested in 3.92M Vaxcyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools